相似文献
1
Kinetic analysis of platelet monoamine oxidase in chronic schizophrenia.
Life Sci. 1981 Apr 27;28(17):1947-51. doi: 10.1016/0024-3205(81)90303-9.
2
Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
Psychiatry Res. 1979 Oct;1(2):179-85. doi: 10.1016/0165-1781(79)90059-3.
3
Platelet monoamine oxidase in chronic schizophrenia.
Am J Psychiatry. 1977 Jul;134(7):805-7. doi: 10.1176/ajp.134.7.805.
4
Platelet monoamine oxidase in schizophrenia with beta-phenylethylamine and benzylamine as substrates.
Biol Psychiatry. 1982 Apr;17(4):479-83.
5
Platelet monoamine oxidase activity in schizophrenic families - kinetic aspects.
Clin Genet. 1981 May;19(5):405-9. doi: 10.1111/j.1399-0004.1981.tb00735.x.
6
An endogenous inhibitor of platelet MAO activity in chronic schizophrenia: failure to replicate.
Am J Psychiatry. 1979 Oct;136(10):1336-7. doi: 10.1176/ajp.136.10.1336.
7
Sources of error in the determination of platelet monoamine oxidase: a review of methods.
Schizophr Bull. 1980;6(2):245-53. doi: 10.1093/schbul/6.2.245.
8
Platelet monoamine oxidase activity in chronic schizophrenia.
Indian J Med Res. 1987 Jul;86:79-83.
9
Platelet monoamine oxidase activity in schizophrenia.
Am J Psychiatry. 1976 Oct;133(10):1191-3. doi: 10.1176/ajp.133.10.1191.
10
Platelet monoamine oxidase activity and schizophrenia.
Arch Gen Psychiatry. 1980 Mar;37(3):357. doi: 10.1001/archpsyc.1980.01780160127015.
引用本文的文献
1
Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia.
Psychopharmacology (Berl). 1995 Mar;118(2):206-12. doi: 10.1007/BF02245841.
2
Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment?
Psychopharmacology (Berl). 1983;79(2-3):177-9. doi: 10.1007/BF00427807.
Zotero 插件